News | November 18, 2024
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
February 29, 2024
The American Bar Association Antitrust Law Section has published the article “Difference-in-Differences Renaissance and Implications for Antitrust Economic Analyses” by Director Jéssica Dutra. Recent advancements in econometrics have shown that the classic formulation of a difference-in-differences (DiD) – Two-way Fixed Effects – although fairly intuitive, may yield a miscalculated magnitude of the policy effect size, potentially going as far as providing an estimate in the opposite direction of the actual effect. In her article, Jéssica shows that by choosing the appropriate specification under the new developments of DiD, antitrust experts can ensure that antitrust enforcement remains grounded in sound economic principles and evidence-based reasoning.
Read the article here (ABA membership required):
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Under Dr. Guyer’s leadership, the new Engineering & Scientific Consulting practice will provide the critical research, analysis, and investigations expertise necessary to solve the challenging science, engineering, and regulatory questions behind why products fail and the implications for stakeholders.
The US Music Industries: Jobs & Benefits — 2024 Report
Robert Stoner and Jéssica Dutra have recently published The U.S. Music Industries: Jobs & Benefits—2024 Report for the Recording Industry Association of America where we measure the music industries’ economic impact nationwide, which overall contribute $212 billion to the GDP and account for 2.5 million jobs.